Back
Lifecore Biomedical Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
62
LFCR
Lifecore Biomedical
Last Price:
6.96
Seasonality Move:
4.04%
Sell
10
NBY
NovaBay Pharmaceuticals
Last Price:
0.49
Seasonality Move:
-6.51%
Buy
62
Lifecore Biomedical (LFCR)
is a Buy
Is Lifecore Biomedical a Buy, Sell or Hold?
- The current Lifecore Biomedical [LFCR] share price is $6.96. The Score for LFCR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- LFCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
10
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.49. The Score for NBY is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
LFCR Stock Price Chart
What is Lifecore Biomedical's stock price today?
-
The Lifecore Biomedical share price today is $6.96
The current trend is moderately bearish and LFCR is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
LFCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 47.37 | Sell |
| Chaikin Money Flow: | -138936 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.92 - 7.64) | Sell |
| Bollinger Bands (100): | (4.75 - 6.85) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 30.61 | Sell |
| Chaikin Money Flow: | -90144 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.69) | Sell |
| Bollinger Bands (100): | (0.5 - 0.7) | Sell |
LFCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.45 | Sell |
| 20-day SMA: | 7.41 | Sell |
| 50-day SMA: | 6.4 | Buy |
| 200-day SMA: | 5.86 | Buy |
| 8-day EMA: | 7.4 | Sell |
| 20-day EMA: | 7.26 | Sell |
| 50-day EMA: | 6.66 | Buy |
| 200-day EMA: | 6.15 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.56 | Sell |
| 20-day SMA: | 0.59 | Sell |
| 50-day SMA: | 0.64 | Sell |
| 200-day SMA: | 1.93 | Sell |
| 8-day EMA: | 0.55 | Sell |
| 20-day EMA: | 0.59 | Sell |
| 50-day EMA: | 0.65 | Sell |
| 200-day EMA: | 4.79 | Sell |
Lifecore Biomedical Earnings Growth & LFCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $1.21 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Lifecore Biomedical Technical Analysis
| Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||